Press Release: HAVN Life Announces Departure of Rick Brar as Director
Press Release: HAVN Life Announces Departure of Rick Brar as Director
HAVN Life Announces Departure of Rick Brar as Director
HAvn Life宣佈裏克·布拉爾(Rick Brar)辭去董事一職
Canada NewsWire
加拿大新聞通訊社
VANCOUVER, BC, Oct. 25, 2021
不列顛哥倫比亞省温哥華，2021年10月25日
VANCOUVER, BC, Oct. 25, 2021 /CNW/ - HAVN Life Sciences Inc. (CSE : HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") announces the departure of Mr. Rick Brar as Vice-Chair of the board of directors of the Company ("Board") and as a director of the Company, effective immediately. The Company expresses its appreciation for Mr. Brar's services to the Company and wishes him well in his future endeavours.
温哥華，不列顛哥倫比亞省，2021年10月25日/cnw/-HAVN生命科學公司(CSE：HAVN)(場外交易代碼：HAVLF)(證券交易所代碼：HAVLF)(以下簡稱“公司”或“HAVN生命”)宣佈，Rick Brar先生辭去公司董事會(“董事會”)副主席兼公司董事職務，即刻生效。公司對布拉爾先生為公司提供的服務表示感謝，並祝願他在未來的工作中一切順利。
On behalf of the Board, Mr. Vic Neufeld, Chairman of the Board, stated, "Mr. Brar has been instrumental in helping HAVN Life navigate the psychedelic sector as a start-up company in a nascent industry. We recognize the time commitments he has with his involvement in other businesses and truly appreciate his efforts and participation in our journey."
董事會主席維克·紐菲爾德先生代表董事會説：“布拉爾先生在幫助HAVN人壽作為一個新興行業的初創公司駕馭迷幻領域發揮了重要作用。我們認識到他在參與其他業務方面所投入的時間，並對他的努力和參與我們的旅程表示由衷的感謝。”
On Behalf of The Board of Directors
我謹代表董事會
Tim Moore
蒂姆·摩爾
CEO
首席執行官
About HAVN Life Sciences Inc.
關於HAVN生命科學公司
HAVN Life Sciences Inc. is a Canadian biotechnology company pursuing standardized extraction of psychoactive compounds, the development of natural healthcare products, and innovative mental health treatment to support brain health and enhance the capabilities of the mind. Learn more at: havnlife.com and follow us on Facebook, Twitter and Instagram.
HAvn生命科學公司是一家加拿大生物技術公司，致力於精神活性化合物的標準化提取、天然保健產品的開發和創新的精神健康治療，以支持大腦健康和增強智力能力。要了解更多信息，請訪問havnlife.com，並在Facebook、Twitter和Instagram上關注我們。
The CSE has not reviewed, approved or disapproved the content of this press release
CSE未審核、批准或不批准本新聞稿的內容
SOURCE HAVN Life Sciences Inc.
來源：HAVN生命科學公司。
View original content: http://www.newswire.ca/en/releases/archive/October2021/25/c0276.html
查看原創內容：http://www.newswire.ca/en/releases/archive/October2021/25/c0276.html
/CONTACT:
/聯繫方式：
Investor Relations: ir@havnlife.com 604 359 0060; Media: savi@emergence-creative.com 647 896-8078
投資者關係部：IR@havnlife.com 604 359 0060；媒體：Savi@Emerging-Creative.com 647 896-8078
/Web site: https://havnlife.com/
網址：https://havnlife.com/
Copyright CNW Group 2021
版權所有CNW集團2021
譯文內容由第三人軟體翻譯。